Call Today: 800-889-3898
Contact us for free information or to start a free case review.
Classified as an immunosuppressant medication, Raptiva is a medication that, when injected once a week, can treat the unsightly red patches associated with psoriasis. Raptiva, which was first approved by the Food and Drug Administration (FDA) in 2003, is made and distributed by Genentech and Merck Serono.
Tragically, however, Raptiva is known to cause a few potentially fatal side effects, including:
To date, the FDA has received three reports of Raptiva deaths due to PML.
Given the severity of Raptiva side effects, patients injured after taking Raptiva, as well as families surviving deceased Raptiva patients, will be entitled to compensation for their injuries and losses.
Patients with the highest risk of developing life-threatening Raptiva side effects include those with a history of:
Similarly, having contact with a person who has recently received a "live" vaccine will also increase Raptiva patients' risk of developing potentially fatal health problems.
To reduce the risk of developing serious Raptiva complications, patients should:
On April 8, 2009, Genentech announced that it was performing a phased withdrawal of Raptiva from the U.S. market. Although the FDA had mandated that Genentech increase the warnings on Raptiva's label twice in the previous six months, it had not yet forced Genentech to pull this drug off the market. Genentech's withdrawal of Raptiva was voluntary.
Currently, about 2,000 Americans use Raptiva. Worldwide, 46,000 people have undergone Raptiva treatments.
Those injured after taking Raptiva, as well as families of deceased Raptiva patients, should meet with a Raptiva lawyer to:
To encourage affected individuals to seek the compensation they deserve, Raptiva lawyers offer these initial consultations for free and work on contingency – so no payment for legal services is due until (or unless) the case is won.
Has your loved one died after taking Raptiva? If so, you should contact our Raptiva lawyer immediately for legal advice and help. You may qualify to recover compensation for your losses.
The U.S. Food and Drug Administration (FDA) announced a voluntary Raptiva recall, April 8, 2009. The Psoriasis drug’s manufacturer, Genentech, announced the voluntary Raptiva recall and has begun phasing the drug off the U.S. market. R...
Copyright © 2001 - 2012 Online Lawyer Source | Legal Marketing Site Designed by eJustice
ATTORNEY ADVERTISEMENT—Thank you for your visit. The content published on this website was not written by medical professionals and should not, at any point, be mistaken for medical advice. Furthermore, the information on this site is intended for educational purposes only and should never interfere with a patient/site visitor and his or her healthcare provider. In addition, viewing the content on this website, requesting additional information, or transmitting information through a contact form should never be considered the formation of an attorney-client relationship. The material published on this site is general and may not apply to your specific circumstances. Every case comes with its own set of unique circumstances; past success discussed on this site does not guarantee future performance. Information found on this website should not be used as incentive to act without seeking counsel from a professional. For more information, please read our disclaimer.